|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/00 | |
| A61K 9/16 | |||
| A61K 9/50 | |||
| A61P 43/00 | |||
| A61P 27/02 | |||
| A61P 27/06 |
| (11) | Number of the document | 2981248 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14727274.4 |
| Date of filing the European patent application | 2014-03-14 | |
| (97) | Date of publication of the European application | 2016-02-10 |
| (45) | Date of publication and mention of the grant of the patent | 2020-09-02 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2014/027885 |
| Date | 2014-03-14 |
| (87) | Number | WO 2014/165308 |
| Date | 2014-10-09 |
| (30) | Number | Date | Country code |
| 201361807092 P | 2013-04-01 | US |
| (72) |
LIU, Hui, US
WAN, Jinping, US
HUGHES, Patrick M., US
|
| (73) |
ALLERGAN, INC.,
2525 Dupont Drive, Irvine, CA 92612,
US
|
| (54) | MICROSPHERE DRUG DELIVERY SYSTEM FOR SUSTAINED INTRAOCULAR RELEASE |
| MICROSPHERE DRUG DELIVERY SYSTEM FOR SUSTAINED INTRAOCULAR RELEASE |